These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34121836)

  • 1. Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus.
    Abdelbaky MSE; El Mamoun TA; Mabrouk FI; Hassan RM
    Egypt J Intern Med; 2021; 33(1):18. PubMed ID: 34121836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
    Lenfant T; Salah S; Leroux G; Bousquet E; Le Guern V; Chasset F; Francès C; Morel N; Chezel J; Papo T; Cacoub P; Mouthon L; Guettrot-Imbert G; Cohen P; Régent A; Mauget-Faÿsse M; Piette JC; Jallouli M; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2020 Dec; 59(12):3807-3816. PubMed ID: 32442312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Potential Risk Factors of Hydroxychloroquine Retinopathy in Patients with Systemic Lupus Erythematosus: Focusing on Asian Population.
    Kao JH; Lai TT; Lu CH; Lan TY; Hsieh YT; Shen CY; Li KJ; Hsieh SC
    J Ocul Pharmacol Ther; 2022 Dec; 38(10):728-733. PubMed ID: 36206015
    [No Abstract]   [Full Text] [Related]  

  • 4. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
    Forte R; Haulani H; Dyrda A; Jürgens I
    Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine-related retinal toxicity.
    Ding HJ; Denniston AK; Rao VK; Gordon C
    Rheumatology (Oxford); 2016 Jun; 55(6):957-67. PubMed ID: 26428520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.
    Petri M; Elkhalifa M; Li J; Magder LS; Goldman DW
    Arthritis Rheumatol; 2020 Mar; 72(3):448-453. PubMed ID: 31532077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
    Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
    Osmani Z; Schrama TJ; Zacouris-Verweij W; Andersen J; Frankel S; Bultink IEM; Cornet A; van Vollenhoven RF
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33795484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients.
    Trefond L; Lhote R; Mathian A; de Chambrun MP; Pha M; Hie M; Miyara M; Papo M; Moyon Q; Taieb D; Saade S; Salem TB; Haroche J; Chasset F; Aubart FC; Zahr N; Amoura Z
    Semin Arthritis Rheum; 2024 Jun; 66():152417. PubMed ID: 38394986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Impact of Early Hydroxychloroquine-Related Retinal Structural Changes in Patients with Systemic Lupus Erythematosus.
    Sallam MA; Beltagi AS; Abdellatif MA; Awadalla MA
    Ophthalmologica; 2021; 244(4):301-308. PubMed ID: 34015786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
    Ameen Ismail A; Sadek SH; Hatata RM
    BMC Ophthalmol; 2022 Nov; 22(1):434. PubMed ID: 36376841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
    Almeida-Brasil CC; Hanly JG; Urowitz M; Clarke AE; Ruiz-Irastorza G; Gordon C; Ramsey-Goldman R; Petri MA; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken C; Isenberg D; Rahman A; Manzi S; Jacobsen S; Lim SS; van Vollenhoven R; Nived O; Jönsen A; Kamen DL; Aranow C; Sánchez-Guerrero J; Gladman DD; Fortin PR; Alarcon GS; Merrill JT; Kalunian K; Ramos-Casals M; Steinsson K; Zoma A; Askanase AD; Khamashta M; Bruce IN; Inanc M; Lukusa L; Bernatsky S
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36396267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy.
    Cheong KX; Ong CJT; Chandrasekaran PR; Zhao J; Teo KYC; Mathur R
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
    Pedrosa T; Kupa LVK; Pasoto SG; Aikawa NE; Borba EF; Duarte NJ; Leon EP; Silva CA; Bonfá E
    Lupus; 2021 Apr; 30(4):554-559. PubMed ID: 33402039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrochloroquine retinopathy: characteristic presentation with review of screening.
    Stelton CR; Connors DB; Walia SS; Walia HS
    Clin Rheumatol; 2013 Jun; 32(6):895-8. PubMed ID: 23515601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.